Bahl & Gaynor Inc. Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bahl & Gaynor Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,028 shares of the medical equipment provider’s stock after selling 217 shares during the quarter. Bahl & Gaynor Inc.’s holdings in Intuitive Surgical were worth $5,234,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Howard Capital Management Group LLC lifted its holdings in shares of Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the period. Van ECK Associates Corp lifted its holdings in Intuitive Surgical by 11.9% in the third quarter. Van ECK Associates Corp now owns 69,623 shares of the medical equipment provider’s stock valued at $35,687,000 after acquiring an additional 7,430 shares during the period. Forum Financial Management LP lifted its holdings in Intuitive Surgical by 1.8% in the third quarter. Forum Financial Management LP now owns 1,966 shares of the medical equipment provider’s stock valued at $966,000 after acquiring an additional 35 shares during the period. Kanawha Capital Management LLC lifted its holdings in Intuitive Surgical by 13.1% in the third quarter. Kanawha Capital Management LLC now owns 519 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 60 shares during the period. Finally, PDS Planning Inc lifted its holdings in Intuitive Surgical by 3.3% in the third quarter. PDS Planning Inc now owns 1,334 shares of the medical equipment provider’s stock valued at $655,000 after acquiring an additional 43 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Evercore ISI boosted their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Finally, Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Down 1.6 %

Shares of NASDAQ:ISRG opened at $557.96 on Wednesday. The business has a fifty day moving average of $571.08 and a two-hundred day moving average of $530.63. The stock has a market cap of $198.73 billion, a P/E ratio of 87.05, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 12,598 shares of company stock worth $7,223,467 in the last three months. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.